News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Jessica Wilson


jessica.wilson@biospace.com


Zold - BioSpace News - By Jessica Wilson
Why Immunomedics (IMMU)' $2 Billion Deal With Seattle Genetics (SGEN) Has venBio Ticked Off and Red-Faced 2/13/2017
TRANSGENE (ENX:TNG) Announces Financial Calendar for 2017 1/5/2017
Smith & Nephew plc (SNN) Loses CFO to Burberry 7/13/2016
Nektar Therapeutics (NKTR) To Present At Jefferies Autumn 2015 Global Healthcare Conference In London 11/17/2015
Hospira Slapped Again By the FDA for Plant Problems 4/16/2015
GI Dynamics (GID.AX) Stock Freefalls After FDA Halts Trial 3/9/2015
Novartis AG (NVS) Unloads RNAi Portfolio to Arrowhead Research Corporation (ARWR) for $35 Million 3/6/2015
Intuitive Surgical (ISRG) Snags $430 Million Defense Department Deal 3/6/2015
Siemens (SI) Investigates Report That Its Healthcare Biz Inflated Numbers by Faking Contracts 3/4/2015
Cardinal Health (CAH) Ponies Up $1.944 Billion Cash for Johnson & Johnson (JNJ)'s Cordis (JNJ) 3/3/2015
NanoString (NSTG) Goes on Hiring Spree After Revenue Jumps 52% in 2014 3/2/2015
NuOrtho Surgical Files for Bankruptcy; Ex-Employees Seek $2.1 Million In Unpaid Wages 2/27/2015
23andMe Wins FDA Approval for First Genetic Test Kit 2/26/2015
Boston Scientific (BSX) Nears $2 Billion Deal to Buy Endo International (ENDP)'s Device Biz: Report 2/26/2015
Novartis AG (NVS)'s Farydak Wins FDA Approval After Setback 2/25/2015
JAMA Questions Theranos's Approach to Science 2/24/2015
Integra LifeSciences (IART) Takes the Ax to 49 Jobs From Its Massachusetts Facilities 2/19/2015
Takeda (TKPYY) Lung Cancer Drug Motesanib Flunks Late Stage Trial 2/19/2015
Sanofi (SAN.PA)'s Cerdelga Shows Promise in Late Stage Trial 2/18/2015
Novartis AG (NVS)'s Potential Blockbuster Heart Drug Could Get FDA Approval by Summer 2/17/2015
Popular Painkiller in Short Supply at Hospitals Following Hospira Recall 2/16/2015
Amgen (AMGN)'s Melanoma Drug Talimogene Laherparepvec Lands a Date With the FDA 2/13/2015
Despite CEO's Comments, Experimental Sarepta (SRPT) Drug Protects Lab Monkeys From Ebola 2/11/2015
$7.3 Million Parting Gift for Now-Former Teva Pharmaceutical Industries (TEVA) Exec 2/10/2015
Genentech (RHHBY)'s Lucentis Is the First Drug to Win Approval for Diabetic Retinopathy 2/10/2015
More Than 60 Side Effect Cases Linked to Merck & Co. (MRK)'s Gardasil 2/9/2015
FDA Commissioner to Step Down After Six Years 2/6/2015
Backed By Eli Lilly (LLY), Roche (RHHBY), and Sanofi (SAN.PA), Startup Lysosomal Therapeutics Bags $20 Million 2/4/2015
Genentech (RHHBY)’s Phase III Study Of Gazyva Showed Significant Benefit In Refractory Indolent Non-Hodgkin’s Lymphoma 2/4/2015
Chimerix, Inc. (CMRX) Abandons Testing of Experimental Ebola Drug in Liberia 2/3/2015
FDA Green Lights Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ) HIV Pills 1/30/2015
First Trial Finds GlaxoSmithKline (GSK) Ebola Shot Safe 1/29/2015
Duke University Expands; Partners Up With Google Inc. (GOOG) to Study What Makes a Healthy Human 1/28/2015
Prominent Duke University Cardiologist Named Deputy Commissioner of the FDA 1/27/2015
FDA Says Yes to Rockwell Medical (RMTI)'s Iron Replacement Drug 1/27/2015
FDA Approves Rockwell Medical (RMTI)l's Triferic™ For Iron Replacement And Maintenance Of Hemoglobin In Hemodialysis Patient 1/26/2015
GlaxoSmithKline (GSK)'s Long-Awaited Ebola Vaccine Due to Arrive in Liberia 1/26/2015
Bogus Versions of Eli Lilly (LLY)'s Cialis Found Entering the U.S. By Mail, Says FDA 1/23/2015
FDA Removes Partial Clinical Hold on CytRx Corporation (CYTR)'s Brain Cancer Trials 1/21/2015
Johnson & Johnson (JNJ) Lands $115 Million to Speed Up Development of Ebola Vaccine 1/19/2015
Gilead (GILD)'s India Patent Roadblock May Spur More Sovaldi Copies 1/15/2015
Pfizer (PFE)'s Working on Once-a-Year Anti-Cholesterol Shot 1/15/2015
Johnson & Johnson (JNJ) Strikes $509 Million Alzheimer's Deal With AC Immune SA 1/12/2015
FDA Green Lights Daiichi Sankyo (DSNKY)'s New Anti-Clotting Drug 1/9/2015
Novartis AG (NVS) Submits Two Lung Drugs for FDA Approval; Analysts Question Decision 1/8/2015
KaloBios Pharmaceuticals, Inc. (KBIO) Discontinues Lung Infection Drug, Stock Sinks 1/7/2015
Johnson & Johnson (JNJ) Starts Ebola Vaccine Testing in Humans 1/6/2015
Merck & Co. (MRK), NewLink Genetics Ebola Vaccine Trial Resumes in Geneva 1/5/2015
TxCell, Ferring B.V. Strike €75 Million Plus Deal 1/2/2015
Vanda Pharmaceuticals, Inc. (VNDA) Leaps After Regaining Drug Rights From Novartis AG (NVS) 12/24/2014
Oragenics, Inc. (OGEN) Exploring Strategic Alternatives for OTC Probiotics Biz 12/23/2014
NewLink Genetics, Merck & Co. (MRK) Nabs $30 Million Government Contract For Ebola 12/23/2014
Second Phase Of GlaxoSmithKline (GSK)'s Ebola Vaccine Delayed 12/22/2014
GlaxoSmithKline (GSK)'s Experimental Shingles Vaccine Hits Goal In Late-Stage Study 12/19/2014
United Therapeutics Corporation (UTHR) Cuts Top Executive's Pay; Names Co-CEO 12/17/2014
FDA Approves Novartis AG (NVS) Drug For Rare Hormonal Disorder 12/17/2014
California Institute for Regenerative Medicine Takes Back $19 Million Alzheimer's Program Loan Award From Bay Area's StemCells Inc. (STEM) 12/16/2014
Actavis (ACT) Ordered To Keep Selling Alzheimer's Pill 12/12/2014
Bill & Melinda Gates Foundation-Backed Group Commits $300 Million To Ebola 12/11/2014
Germany Bans 80 Drugs For Insufficient Trials By gvk bioSciences Private Limited 12/11/2014
Spark Therapeutics Strikes $280 Million Hemophilia B Pact With Pfizer (PFE) 12/9/2014
Speedy FDA Approval For Amgen (AMGN)'s Leukemia Immunotherapy BLINCYTO 12/5/2014
Results Of City of Hope Clinical Trial Supports Change To Standard Of Care For HIV Lymphoma 12/5/2014
Otsuka Pharmaceutical Co., Ltd. Buys AVANIR Pharmaceuticals (AVNR) For $3.5 Billion 12/2/2014
Sanofi (SAN.PA), Pozen, Inc. (POZN) Terminate U.S. License Agreement For Gastric Ulcer Drugs 12/1/2014
Amgen (AMGN), AstraZeneca PLC (AZN)'s Brodalumab Phase 3 Study Met All Primary Endpoints Against Johnson & Johnson (JNJ)'s Stelara 11/26/2014
Bayer AG (BAYZF) Continues Efforts To Sell Diabetes Device Unit 11/25/2014
Regeneron (REGN), ReGen Therapeutics Plc (RGT.L) Eczema Drug Dupilumab Gets FDA Breakthrough Therapy Designation 11/24/2014
Regeneus (RGS.AX) Streamlines Management Structure, Operations And Reduces Costs 11/24/2014
Camurus, Braeburn Pharmaceutical Ink Licensing Deal Worth Up To $151 Million 11/21/2014
Sanofi (SAN.PA) And Regeneron (REGN)'s Alirocumab Ph3 Trials Met Primary Efficacy Endpoint 11/20/2014
Layoff Plans Changed; 199 Ricerca Biosciences CRO Jobs Saved 11/19/2014
FDA Approves Genzyme Corporation (GENZ)’s Lemtrada For MS 11/17/2014
Mallinckrodt Pharmaceuticals (MNK)'s Generic ADHD Drug Does Not Measure Up To Johnson & Johnson (JNJ)'s Concerta: FDA 11/14/2014
Boehringer Ingelheim Corporation Passes on Anthera, Inc.'s CV Antibody Option 11/13/2014
Servier Bets $1 Billion+ On Intarcia Therapeutics, Inc.'s Diabetes Device 11/13/2014
SSF's Threshold Pharmaceuticals, Inc. (THLD) Snags Fast Track Status For Experimental Cancer Drug TH-302 11/11/2014
Merck & Co. (MRK)'s Four-Week Hep C Regimen With Gilead Sciences, Inc. (GILD)'s Sovaldi Fails To Deliver 11/11/2014
Novartis AG (NVS)'s Panobinostat Fails To Win FDA Panel Support 11/7/2014
Eli Lilly (LLY) Wins FDA Approval For Gastric Cancer Combination Drug 11/6/2014
Regeneron (REGN)'s Earnings Disappoint; Dumps More And More Cash On R&D 11/6/2014
Nine Out Of 10 Lost Weight With Novo Nordisk A/S (NVO)'s Obesity Drug Liraglutide 11/5/2014
Geron Corporation (GERN) Soars As The FDA Removes Full Clinical Hold On Imetelstat 11/4/2014
Novo Nordisk A/S (NVO) Commits $130 Million In Diabetes Research In Denmark 10/31/2014
Novo Nordisk A/S (NVO) More Mindful On Timing Of U.S. Tresiba Launch 10/30/2014
Xencor Regains All Rights From Amgen (AMGN) To Rare AutoImmune Disease Drug, Dumps Arthritis Hopes 10/29/2014
Amgen (AMGN), Ono Pharmaceutical Company, Ltd., Sanofi (SAN.PA) Team Up With Academia On Proteins Project 10/28/2014
Pain Therapeutics (PTIE) Tanks As Pfizer (PFE) Walks Away From Remoxy® Deal 10/27/2014
FDA Postpones Its Final Decision On NPS Pharmaceuticals, Inc. (NPSP)'s Natpara 10/24/2014
Vertex Pharmaceuticals (MA) (VRTX) Surges As FDA Advisory Panel Approves Kalydeco's Label Expansion 10/22/2014
Genentech (RHHBY), NewLink Genetics Strike $1 Billion+ Cancer Deal 10/21/2014
Omeros Corporation (OMER) Suspends Enrollment In Huntington's Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday 10/21/2014
Novartis AG (NVS)'s Leukemia Drug CTL01 Clears Cancer In 90 Percent Of Patients 10/20/2014
Roche (RHHBY), Merck & Co. (MRK) Extend Immunotherapy Battle To Breast Cancer 10/17/2014
FDA Staff Recommend Pfizer (PFE) Keep Its Black Box Warnings For Chantix 10/15/2014
Novartis AG (NVS)'s Secukinumab Has Consistent Activity In Psoriasis 10/14/2014
Amgen (AMGN)'s Leukemia Drug Blinatumomab Gets FDA Priority Review 10/10/2014
Second Biotech Accelerator, Indie Bio, Launches In SF And Ireland 10/9/2014
Biotech Startup Novare Pharmaceuticals Launches In Boston 10/8/2014
Roche (RHHBY)'s Severin Schwan Still The Best Paid Swiss CEO 10/8/2014
SSF-Based Sunesis Pharmaceuticals, Inc. (SNSS)'s Shares Crater After Failed Phase 3 Cancer Drug Study 10/7/2014
Bay Area Biotech Dermira Increases Deal Size 46% To $117 Million 10/3/2014
FDA Slaps Hospira, Inc. For Drug Manufacturing Violations 10/3/2014
Gilead Sciences, Inc. (GILD) Will Employ 500 People At New SoCal Campus 10/2/2014
Endocyte, Inc. (ECYT) Faces Big Decisions On Cancer Drug Vintafolide 10/1/2014
Genentech (RHHBY)'s New Breast Cancer Drug Greatly Extends Survival Rates 9/30/2014
Biotech Layoffs Often Go Hand-In-Hand With CEO Pay Raises 9/26/2014
Valueact Places CEO On Valeant Pharmaceuticals International (VRX)'s Board In Effort To Force Allergan Inc. (AGN) Takeover 9/26/2014
Convicted ImClone Systems (LLY) Boss Becomes Chief Of Innovation At Kadmon Corporation While Brother Harlan W. Waksal, M.D Takes CEO Post 9/26/2014
Gilead Sciences, Inc. (GILD)'s Single Tablet HIV Regimen Meets Goals In Two Phase 3 Studies 9/25/2014
Swiss Biotech Firm Molecular Partners AG Plans $134 Million IPO 9/23/2014
Gilead Sciences, Inc. (GILD)'s Experimental Drug Simtuzumab Fails Mid-Stage Study 9/22/2014
Auxilium Pharmaceuticals (AUXL), VIVUS, Inc. (VVUS)'s Faster-Acting Erectile Dysfunction Drug Wins FDA Approval 9/19/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
FDA Approves Baxter International, Inc. (BAX), Halozyme Therapeutics, Inc. (HALO)'s HYQVIA 9/15/2014
FDA's Surprise Visit To Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS)'s Pressures Stock 9/12/2014
Abbott Laboratories (ABT) Invests $60 Million, Expects 500 New Jobs In Malaysia 9/11/2014
GlaxoSmithKline (GSK)'s Consumer Health Business Also Investigated, New Documents Say 9/10/2014
Johnson & Johnson (JNJ) Seeks Buyer For Struggling Medical Device Unit Cordis Corporation (JNJ); Deal Could Fetch Up To $2 Billion 8/29/2014
Merck Serono Breaks Ground On $105 Million Plant; Will Be The Company's Second Largest Manufacturing Facility Worldwide 8/28/2014
Drug Giants Merck & Co. (MRK) And Pfizer (PFE) Forge Cancer Pact 8/27/2014
Vaccinogen Plans Move To Baltimore After $80 Million In New Funding; Will Increase Headcount By 300 Percent 8/27/2014
Tiny Biotech Advaxis, Inc. Inks Another Pact With Merck & Co. (MRK) To Test Immune Therapies Against Prostate Cancer 8/26/2014
Unnamed Drug Firm May Invest Up To €1 Billion In Ireland, Hundreds Of New Jobs Expected 8/22/2014
Illumina, Inc. (ILMN) Partners With AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) To Create New Genetic Tests For Cancer 8/21/2014
More Exits From Ranbaxy Laboratories (RANBAXY.BO)' Top Management Team 8/21/2014
Allergan Inc. (AGN) CFO Steps Down In Midst Of Hostile Takeover Bid By Valeant Pharmaceuticals International (VRX) 8/20/2014
Silicon Valley’s Hottest Tech Accelerator, Y Combinator, To Debut Biotech Startups 8/19/2014
Merck & Co. (MRK) Wins FDA Approval For New Type Of Sleeping Pill 8/15/2014
Shire Confirms Jobs Are Safe At Northumberland-Based SCM Pharma Limited 8/15/2014
Rigel Pharmaceuticals, Inc. (RIGL) Experimental Eye Drug R348 Fails Mid-Stage Study 8/14/2014
Intercept Pharmaceuticals (ICPT) Soars As Liver Drug Found Effective In Mid-Stage Trial 8/13/2014
Bay Area Biotech Firm Tobira Therapeutics Inc. Tables $74 Million IPO 8/11/2014
AstraZeneca PLC (AZN), Shire Slip As The U.S. Looks To Stop Tax Inversion Deals 8/7/2014
San Diego's Cytori Therapeutics, Inc. (CYTX) Crashes As Safety Concerns Suspend Athena Trials 8/7/2014
MD Anderson Cancer Center Postdoc Faked Results Of Novartis AG (NVS) Brain Tumor Study 8/7/2014
Insmed Incorporated (INSM) Tanks As Phase 3 Plans Are Needed For ARIKAYCE, Delaying FDA Approval 8/5/2014
Woman Alleges Pfizer (PFE) Drug Left Her In Wheelchair 8/4/2014



//-->